Back to Peptide Pedia
Growth Hormone
Limited Research

PEG-MGF

PEG-MGF

Pegylated mechano growth factor.

Also known as: Pegylated Mechano Growth Factor

Research dose range100–250 mcg (research models)
Route studiedSubcutaneous / intramuscular
Study duration2–3× weekly, shorter study blocks
Storage2–8 °C reconstituted

Overview

PEG-MGF is a pegylated form of mechano growth factor (an IGF-1 splice variant) studied for extended stability in muscle-repair research.

Key research findings

Mechano Growth Factor is a splice variant of IGF-1 expressed in muscle after mechanical overload, studied for activating satellite (muscle stem) cells and local repair. The pegylated (PEG) form is stabilized to extend its otherwise very short half-life for research use.

Mechanism of action

Studied for activating satellite cells and promoting muscle-tissue repair, with pegylation extending its circulating half-life.

Molecular information

Weight~2,888 Da (peptide, pre-PEG)
Length24-amino-acid C-terminal MGF region
TypePegylated IGF-1 splice variant (MGF)

PEGylation shields the peptide from rapid degradation, extending its window of activity.

Pharmacokinetics

Peak: ~few hoursHalf-life: ~1–3 days (pegylated)Cleared: ~7 days
Peak · 0.1dHalf-life · 1d

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Muscle-repair research
  • Satellite-cell studies
  • Tissue-growth investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Standard referenceAmount: 100–200 mcgFrequency: 2–3× weeklyRoute: Subcutaneous
Localized referenceAmount: 100–250 mcgFrequency: Post-activity near siteRoute: Intramuscular

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Week 1–2

    Satellite-cell activation and local repair signaling reported in muscle-research models.

  2. Week 3–4

    Muscle-remodeling changes reported; cycles are typically kept short.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

IGF-1 LR3

Related IGF-1 variants; overlapping pathways.

Use caution

Follistatin 344

Distinct myostatin pathway; co-studied in growth research.

Compatible

Thymosin Beta-4

Complementary repair pathways in muscle research.

Compatible

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Avoid shaking to preserve the pegylated peptide.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved into a clear solution.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solution requires 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Generally reported as well tolerated in research; mild injection-site reactions are the most common signal.
  • As an IGF-1 variant, theoretical growth-factor proliferation considerations are noted in the literature.

References & further reading

Mechano Growth Factor and muscle satellite cells (review)

PreclinicalMGFmuscle repair

Review of the IGF-1 splice variant MGF and its role in mechanically-induced muscle repair and satellite-cell activation.

View study

Topics

mgfmuscleigf variant

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Limited Research

Sparse published data; largely preliminary or anecdotal.

Quick reference
Dose range100–250 mcg (research models)
RouteSubcutaneous / intramuscular
Duration2–3× weekly, shorter study blocks
Storage2–8 °C reconstituted
Half-life~1–3 days (pegylated)
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue